All In MedTech

Device Trial Radar · NCT03152136

A Pilot Study of the Cala ONE Device for Essential Tremor

A Pilot Study to Evaluate the Safety and Initial Effectiveness of the Cala ONE Device to Repeatably Aid in the Symptomatic Relief of Essential Tremor

Last checked: Nov 19, 2026Latest source record: Apr 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

62

Actual

Start

Jul 26, 2017

Primary completion

Mar 8, 2018

Study completion Mar 8, 2018

Sponsor

Lead sponsor
Cala Health, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 12, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, multi-center, randomized, controlled study designed to evaluate safety and repeatable effectiveness. Subjects will be randomized 2:1:1 to transcutaneous afferent patterned stimulation (TAPS), sham, or 'no intervention', respectively. Subjects randomized to the TAPS and sham arms will be blinded to their randomization assignments for the first two weeks of participation (controlled phase). After the first two weeks, all subjects will be crossed over to TAPS (open-label phase) for 2 weeks. During study participation, all subjects are to remain on a stable dosage of medications prescribed for the treatment of essential tremor, if applicable.

Conditions

  • Essential Tremor

Interventions

  • Cala ONE deviceDevice

    The Cala ONE device is a wrist-worn stimulator which applies a tremor-customized stimulation pattern to an individual's nerves.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change in Tremor PowerTime frame: Mean tremor power pre stimulation over two weeks of device usage as compared to mean tremor power post stimulation over two weeks of device usage.

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Personal Care Neurology

    Oakland, California

  • Movement & Neuroperformance Center

    Denver, Colorado

  • Kansas University Medical Center

    Kansas City, Kansas

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.